CIBC Private Wealth Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

CIBC Private Wealth Group’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.24M	Sell	1,950,000 -450,257	-19%	-$618K	﹤0.01%	553
2025 Q3	$3.24M	Sell	2,400,257 -50,143	-2%	-$56.9K	0.01%	497
2025 Q2	$2.32M	Buy	2,450,400 +210,400	+9%	+$136K	﹤0.01%	529
2025 Q1	$1.12M	Buy	+2,240,000	New	+$1.41M	﹤0.01%	631
2024 Q4	–	Sell	-50,010	Closed	-$78.5K	–	3098
2024 Q3	$78.5K	Buy	50,010 +50,000	+500,000%	+$89K	﹤0.01%	1598
2024 Q2	$16	Hold	10	–	–	﹤0.01%	3116
2024 Q1	$23	Sell	10 -150,090	-100%	-$322K	﹤0.01%	3037
2023 Q4	$230K	Buy	+150,100	New	+$178K	﹤0.01%	1022
2023 Q3	–	Sell	-30,000	Closed	-$68.7K	–	1114
2023 Q2	$68.7K	Hold	30,000	–	–	﹤0.01%	857
2023 Q1	$72.9K	Hold	30,000	–	–	﹤0.01%	859
2022 Q4	$57	Hold	30,000	–	–	﹤0.01%	837
2022 Q3	$72K	Buy	+30,000	New	+$83K	﹤0.01%	882

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CIBC Private Wealth Group's LXRX Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Lexicon Pharmaceuticals (LXRX) stake by 19% in Q4 2025, selling an estimated $618K and leaving 1,950,000 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #553.

CIBC Private Wealth Group first reported a position in LXRX in Q3 2022 and has held it in 12 quarters since. The position peaked at $3.24M in Q3 2025. 125 funds tracked by Wall St. Rank hold LXRX as of Q4 2025.

CIBC Private Wealth Group held 1,950,000 shares of Lexicon Pharmaceuticals worth $2.24M as of Q4 2025.
CIBC Private Wealth Group sold 450,257 Lexicon Pharmaceuticals shares in Q4 2025, an estimated $618K.
Lexicon Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #553 holding.
CIBC Private Wealth Group first reported a position in Lexicon Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
CIBC Private Wealth Group's Lexicon Pharmaceuticals position peaked at $3.24M in Q3 2025.
125 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.